Evidence map›Paper›PMID 37077998›Full record

ArticleRSC advances2023

A self-indicating and antibacterial gelatine-chitosan blended hydrogel enabling real-time quality control and sustained bioactive agent delivery.

Wing-Fu Lai, Obireddy Sreekanth Reddy, Lucy Law, Haicui Wu, Wing-Tak Wong

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Wing-Fu LaiDepartment of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Zhejiang 310012 China rori0610@graduate.hku.hk.ORCID https://orcid.org/0000-0003-0585-6396
Obireddy Sreekanth ReddyDepartment of Chemistry, Sri Krishnadevaraya University Anantapur 515003 India.ORCID https://orcid.org/0000-0002-5825-9547
Lucy LawDepartment of Applied Biology and Chemical Technology, Hong Kong Polytechnic University Hong Kong Special Administrative Region China.
Haicui WuDepartment of Applied Biology and Chemical Technology, Hong Kong Polytechnic University Hong Kong Special Administrative Region China.
Wing-Tak WongDepartment of Applied Biology and Chemical Technology, Hong Kong Polytechnic University Hong Kong Special Administrative Region China.
Hong Kong Polytechnic University · HKSri Krishnadevaraya University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogels are one type of materials that are widely exploited for bioactive agent delivery, partly owing to their high biocompatibility and low toxicity. When hydrogels are used as carriers, their performance in agent loading and sustained agent release are predominately determined by the gel structure, which can be largely affected by variations during gel preparation. Till now, effective and easy methods to enable monitoring of such variations in real time have been lacking, making quality control of the generated gel-based carrier technically challenging. To address this technical gap, in this study we take advantage of the clusteroluminogenic properties of gelatine and chitosan to generate a crosslinked blended hydrogel which not only shows intrinsic antibacterial properties and high tunability in delivery performance but also shows a self-indicating capacity to enable quality control during hydrogel preparation. Upon fitting the curves of agent release into different kinetic models, the release profiles of the agent-loaded gels have been found to follow the Higuchi model well, with the non-Fickian mechanism being the major mechanism of the release process. Along with their high efficiency in agent loading, our gels warrant further exploitation for use in bioactive agent delivery and related biomedical applications.

Identifiers

PMID37077998
PMCPMC10107026
OpenAlexW4366211892

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.